<?xml version='1.0' encoding='utf-8'?>
<document id="20045985"><sentence text="Prediction of drug-drug interactions based on time-dependent inhibition from high throughput screening of cytochrome P450 3A4 inhibition." /><sentence text="A method of assessing the risk of drug-drug interaction (DDI) caused by mechanism-based inhibition (MBI) was developed for early-stage drug development using cytochrome P450 (CYP) 3A4 inhibition screening data" /><sentence text=" CYP3A4 inhibition was evaluated using a fluorescent substrate with or without preincubation containing an inhibitor" /><sentence text=" The results showed that five well-known mechanism-based inhibitors, but not the competitive inhibitor ketoconazole, had lower IC(50) after preincubation, suggesting the utility of the IC(50) shift by preincubation to discern mechanism-based inhibitors"><entity charOffset="103-115" id="DDI-PubMed.20045985.s4.e0" text="ketoconazole" /></sentence><sentence text=" A method to approximately predict the change in the area under the concentration-time curve (AUC) of a co-administered drug by MBI was found using IC(50) shift data and the unbound mean plasma concentration of the inhibitor" /><sentence text=" From our predictions of change in the AUC for 38 drugs using this method, all mechanism-based inhibitors causing change in the AUC of more than 200% were predicted to be high risk" /><sentence text=" In conclusion, our method provides a simple assessment of the risk of DDI from mechanism-based inhibitors, especially in the early stages of drug development" /><sentence text="" /></document>